Scientists use patients' own lung fluid cells to fight advanced cancer

NCT ID NCT07443020

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests a new treatment for people whose cancer has spread to the lining of the lungs (pleura) or who have mesothelioma. Doctors collect immune cells from the patient's own lung fluid, grow them in a lab, and then put them back into the chest through a tube along with a drug that boosts their activity. The goal is to see if this approach is safe and can shrink tumors or ease symptoms. The study involves about 10 participants and includes a short hospital stay.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT MESOTHELIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant mesothelioma Mesothelioma, Malignant Pleural Effusion, Malignant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AHN West Penn Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.